{"@id":"https://bioecon.ru/technology/transgenic-animal-model-generation/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/transgenic-animal-model-generation/","json":"https://cn.bioecon.ru/api/v1/technology/transgenic-animal-model-generation/index.json"},"id":"transgenic-animal-model-generation","industries":["research-tools","equipment","biomanufacturing","pharma"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/research-tools/","https://bioecon.ru/industries/equipment/","https://bioecon.ru/industries/biomanufacturing/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/shandong-shunfeng-biotechnology/","https://bioecon.ru/companies/inari-agriculture/","https://bioecon.ru/companies/ondemandbio/","https://bioecon.ru/companies/string-bio/","https://bioecon.ru/companies/farmship/","https://bioecon.ru/companies/helaina/","https://bioecon.ru/companies/kheiron-biotech/","https://bioecon.ru/companies/orf-genetics/","https://bioecon.ru/companies/change-foods/","https://bioecon.ru/companies/bioinfood/","https://bioecon.ru/companies/human-longevity/","https://bioecon.ru/companies/impacfat/"]},"maturity":8,"name":"高保真CRISPR/Cas9基因编辑转基因与人源化疾病动物模型构建技术","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"高特异性向导gRNA与单链修复模板设计"},{"n":2,"title":"受精卵雄原核微量显微注射与电转导"},{"n":3,"title":"SPF级无特定病原体假孕代孕母鼠受精卵移植"},{"n":4,"title":"靶向高深度NGS测序与脱靶效应精准金标准质检"}],"summary":"融合高保真CRISPR/Cas9核糖核蛋白前核显微注射、胚胎干细胞（ESC）基因打靶与piggyBac转座子整合技术，在小鼠、大鼠及实验兔中高效率构建携带人类临床罕见致病突变、条件性基因敲除（Cre-LoxP）以及人类全长基因原位替换的精准疾病动物模型。","url":"/technology/transgenic-animal-model-generation/","verified":"2026-11-22"}